Ying Fan

2017- School of Psychological and Cognitive Sciences Peking Univ 
"Ying Fan"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lin S, Yue J, Guan X, et al. (2019) Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer. Cancer Communications (London, England). 39: 57
Fan Y, Yi Z, D'Agati VD, et al. (2019) Comparison of Kidney Transcriptomic Profiles of Early and Advanced Diabetic Nephropathy Reveals Potential New Mechanisms for Disease Progression. Diabetes
Tu C, Fan Y, Fan J. (2019) Universal Cointegration and Its Applications. Iscience. 19: 986-995
Zeng A, Shen Z, Zhou J, et al. (2019) Increasing trend of scientists to switch between topics. Nature Communications. 10: 3439
Chen Q, He J, Hu G, et al. (2019) Morphological Characteristics and Risk Factors of Myopic Maculopathy in an Older High Myopia Population - Based on the New Classification System (ATN). American Journal of Ophthalmology
Gao H, Wang X, Lin C, et al. (2019) Exosomal MALAT1 derived from ox-LDL-treated endothelial cells induce neutrophil extracellular traps to aggravate atherosclerosis. Biological Chemistry
Chen Q, He J, Yin Y, et al. (2019) Impact of the Morphologic Characteristics of Optic Disc on Choroidal Thickness in Young Myopic Patients. Investigative Ophthalmology & Visual Science. 60: 2958-2967
Han Y, Wang J, Liu W, et al. (2019) Trastuzumab treatment after progression in HER2-positive metastatic breast cancer following relapse of trastuzumab-based regimens: a meta-analysis. Cancer Management and Research. 11: 4699-4706
Zhu A, Yuan P, Wang J, et al. (2019) Apatinib combined with chemotherapy in patients with previously treated advanced breast cancer: An observational study. Oncology Letters. 17: 4768-4778
Li Q, Guan X, Chen S, et al. (2019) Safety, Efficacy and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
See more...